<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39100241</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2667-193X</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Lancet regional health. Americas</Title><ISOAbbreviation>Lancet Reg Health Am</ISOAbbreviation></Journal><ArticleTitle>Prevalence, risk factors, and impact of long COVID in a socially vulnerable community in Brazil: a prospective cohort study.</ArticleTitle><Pagination><StartPage>100839</StartPage><MedlinePgn>100839</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100839</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lana.2024.100839</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID is an emerging global public health issue. Socially vulnerable communities in low- and-middle-income countries were severely impacted by the pandemic and are underrepresented in research. This prospective study aimed to determine the prevalence of long COVID, its impact on health, and associated risk factors in one such community in Rio de Janeiro, Brazil.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 710 individuals aged 18 and older, with confirmed SARS-CoV-2 infection at least three months prior, were enrolled between November 25, 2021, and May 5, 2022. Participants were assessed via telephone or in person using a standardized questionnaire to evaluate their perception of recovery, symptoms, quality of life, and functional status.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Twenty percent of participants did not feel fully recovered, 22% experienced new or persistent symptoms, 26% had worsened functional status, 18% had increased dyspnoea, and 32% reported a worse quality of life. Persistent symptoms included headache, cough, fatigue, muscle pain, and shortness of breath. Dyspnoea during the acute phase was the strongest independent predictor of worsening outcomes. Females and individuals with comorbidities were more likely to report worse recovery, functioning, dyspnoea, and quality of life.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Our findings reveal a high burden of severe and persistent physical and mental health sequelae in a socially vulnerable community following COVID-19.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">UK Foreign, Commonwealth and Development Office and Wellcome Trust Grant (222048/Z/20/Z), Funda&#xe7;&#xe3;o Oswaldo Cruz (FIOCRUZ), Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the Centers for Disease Control and Prevention (CDC).</AbstractText><CopyrightInformation>&#xa9; 2024 Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Azambuja</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastos</LastName><ForeName>Leonardo S L</ForeName><Initials>LSL</Initials><AffiliationInfo><Affiliation>Department of Industrial Engineering (DEI), Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batista-da-Silva</LastName><ForeName>Amanda A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Industrial Engineering (DEI), Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Grazielle Viana</ForeName><Initials>GV</Initials><AffiliationInfo><Affiliation>D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurtz</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Copa Star, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paulo Niemeyer State Brain Institute (IECPN), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Carolina M C</ForeName><Initials>CMC</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o de Desenvolvimento Redes da Mar&#xe9;, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Everton P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o de Desenvolvimento Redes da Mar&#xe9;, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arouca</LastName><ForeName>Luna E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o de Desenvolvimento Redes da Mar&#xe9;, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sejvar</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranzani</LastName><ForeName>Otavio T</ForeName><Initials>OT</Initials><AffiliationInfo><Affiliation>Barcelona Institute for Global Health, ISGlobal, Hospital Cl&#xed;nic-Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamacher</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Industrial Engineering (DEI), Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tecgraf Institute, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozza</LastName><ForeName>Fernando A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Comprehensive Health Research Centre (CHRC), NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Am</MedlineTA><NlmUniqueID>9918232503006676</NlmUniqueID><ISSNLinking>2667-193X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Post-covid condition</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Social vulnerability</Keyword></KeywordList><CoiStatement>The authors declare they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39100241</ArticleId><ArticleId IdType="pmc">PMC11295704</ArticleId><ArticleId IdType="doi">10.1016/j.lana.2024.100839</ArticleId><ArticleId IdType="pii">S2667-193X(24)00166-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Post-COVID conditions: information for healthcare providers. Cent Dis Control Prev. 2020 https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</Citation></Reference><Reference><Citation>NICE  COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020. https://www.nice.org.uk/guidance/NG188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney L.L., Routen A., Gillies C., et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T., Akrami A., et al. A&#xa0;core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med. 2022;10:715&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S., Abbafati C., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.R., Kobayashi T., Callado G.Y., et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3:e168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin A.T., Owusu-Boaitey N., Pugh S., et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Glob Health. 2022;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9136695</ArticleId><ArticleId IdType="pubmed">35618305</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazil  WHO coronavirus disease (COVID-19) dashboard with vaccination data. https://covid19.who.int</Citation></Reference><Reference><Citation>Khor N. United Nations Human Settlements Programme (UN-Habitat); Nairobi,&#xa0;Kenya: 2022. World cities report 2022: envisaging the future of cities.</Citation></Reference><Reference><Citation>Macchia A., Ferrante D., Battistella G., Mariani J., Gonz&#xe1;lez Bernaldo De Quir&#xf3;s F. COVID-19 among the inhabitants of the slums in the city of Buenos Aires: a population-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818811</ArticleId><ArticleId IdType="pubmed">33472790</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W., Reyes L.F., Munblit D., et al. Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet. 2023;402:1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pubmed">37652071</ArticleId></ArticleIdList></Reference><Reference><Citation>A Batista-da-Silva A., T Ranzani O., M De Paulo D., et al. Mar&#xe9; cohort-profile: a prospective cohort study based in a socially vulnerable community during the COVID-19 pandemic in Rio de Janeiro, Brazil. Gates Open Res. 2023;7:22.</Citation></Reference><Reference><Citation>Sigfrid L., Cevik M., Jesudason E., et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista-da-Silva A.A., Ranzani O.T., Paulo D.M. de, et al.  Mare cohort-profile: a prospective cohort study based in a socially vulnerable community during the COVID-19 pandemic in Rio de Janeiro, Brazil. 2023. https://gatesopenresearch.org/articles/7-22</Citation></Reference><Reference><Citation>Ranzani O.T., Silva A.A.B., Peres I.T., et al. Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study. Clin Microbiol Infect. 2022;28:736.e1&#x2013;736.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828302</ArticleId><ArticleId IdType="pubmed">35150884</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista-da-Silva A.A., Moraes C.B., Bozza H.R., et al. Effectiveness of a multicomponent intervention to face the COVID-19 pandemic in Rio de Janeiro's favelas: difference-in-differences analysis. BMJ Glob Health. 2023;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230340</ArticleId><ArticleId IdType="pubmed">37253531</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A., Baumgart A., Evangelidis N., et al. Core outcome measures for Trials in people with coronavirus disease 2019: respiratory failure, multiorgan failure, shortness of breath, and recovery. Crit Care Med. 2021;49:503&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892260</ArticleId><ArticleId IdType="pubmed">33400475</ArticleId></ArticleIdList></Reference><Reference><Citation>MRC breathlessness scales: 1952 and 1959. 2016. https://www.ukri.org/publications/mrc-breathlessness-scales-1952-and-1959/</Citation></Reference><Reference><Citation>WG Short Set on Functioning (WG-SS)  Wash. Group disabil. Stat. https://www.washingtongroup-disability.com/question-sets/wg-short-set-on-functioning-wg-ss/</Citation></Reference><Reference><Citation>EuroQol Research Foundation  EQ-5D-5L user guide. https://euroqol.org/publications/user-guides/</Citation></Reference><Reference><Citation>IBGE  Manual do recenseador parte 2. https://censo2022.ibge.gov.br/media/com_mediaibge/arquivos/bfd69167fb62613effc2bae005e4666d.pdf</Citation></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M., Mudara C., Vika C., et al. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob Health. 2022;10:e1247&#x2013;e1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021;51:1107&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Zayyad H., et al. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. NPJ Vaccines. 2022;7:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten W.M. Chronic pain and mental health disorders. Mayo Clin Proc. 2016;91:955&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">27344405</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., et al. Risk factors associated with Post&#x2212;COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J.Q., Sepand M.R., Bigdelou B., et al. The immune response to COVID-19: does sex matter? Immunology. 2022;166:429&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111683</ArticleId><ArticleId IdType="pubmed">35470422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zajacova A., Lawrence E.M. The relationship between education and health: reducing disparities through a contextual approach. Annu Rev Public Health. 2018;39:273&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5880718</ArticleId><ArticleId IdType="pubmed">29328865</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen T., Rademakers J., Waverijn G., Verheij R., Osborne R., Heijmans M. The role of health literacy in explaining the association between educational attainment and the use of out-of-hours primary care services in chronically ill people: a survey study. BMC Health Serv Res. 2018;18:394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984471</ArticleId><ArticleId IdType="pubmed">29855365</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.-T., Daskalopoulou C., Muniz Terrera G., et al. Education and wealth inequalities in healthy ageing in eight harmonised cohorts in the ATHLOS consortium: a population-based study. Lancet Public Health. 2020;5:e386&#x2013;e394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7739372</ArticleId><ArticleId IdType="pubmed">32619540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>